Human papillomavirus vaccine delivery strategies that achieved high coverage in low- and middle-income countries

LaMontagne, D. Scott; Barge, S; Lê, Nga; Mugisha, Emmanuel; Penny, Mary E.; Gandhi, Sanjay; Janmohamed, Amynah; Kumakech, Edward; Mosqueira, N. Rocio; Nguyen, Nghi Quy; Paul, Proma; Tang, Yuxiao; Minh, T.; Uttekar, Bella Patel; Jumaan, Aisha O.

doi:10.2471/blt.11.08986

Cited by 89 publications

(119 citation statements)

References 19 publications

Supporting

Mentioning

113

Contrasting

Order By: Relevance

“…[12] In Uganda, the results of the HPV vaccination project held in 2008 -2009 also showed a high uptake; in 2008, 99.6% of 3 459 girls received the first dose; and 87.8% completed all 3 doses; while in 2009, 93.2% of 2 385 girls received their first dose, and 86.3% completed all 3 doses. [13] Vaccination coverage in school-based programmes was 82.6% in Peru, 88.9% in 2009 in Uganda, and 96.1% in 2009 in Vietnam. [14] In India, a campaign approach achieved 77.2 -87.8% coverage, whereas monthly delivery achieved 68.4 -83.3% coverage.…”

Section: Discussionmentioning

confidence: 99%

High uptake of Gardasil vaccine among 9 - 12-year-old schoolgirls participating in an HPV vaccination demonstration project in KwaZulu-Natal Province

Moodley

Tathiah²,

Mubaiwa³

et al. 2013

S Afr Med J

View full text Add to dashboard Cite

Corresponding author : I Moodley (moodleyi15@ukzn.ac.za) Background. Cervical cancer is linked to infection of the cervix by oncogenic human papillomavirus (HPV) subtypes. The quadrivalent Gardasil vaccine (against HPV types 6,11, 16, 18), recommended in girls 9 -12 years of age, has been shown to be safe, immunogenic and efficacious, with minimal or no side-effects. Aim. To demonstrate the capacity of school health teams to carry out vaccinations within a school environment. Objectives. To assess the uptake of 3 doses of the vaccine, document lessons learnt and provide recommendations for a national rollout of school-based HPV vaccination for learners. Methods. Female learners (age 9 -12 years) from 31 primary schools in Nongoma and Ceza districts (KwaZulu-Natal province, South Africa) were identified for inclusion in the vaccination programme. The 3 doses of vaccine were administered by existing school health teams. Education and training sessions were held with all stakeholders: provincial departments of health and education; school health teams; primary healthcare nurses; hospital doctors and nurses; private practitioners; school principals, teachers and governing bodies; parents; and community and traditional leaders. Results. The overall uptake of the vaccine was found to be high: 99.7%, 97.9% and 97.8% for the first, second and third doses respectively (N=963). No adverse events were attributed to the HPV vaccine. Conclusion. This project demonstrated the successful implementation of HPV vaccination among learners (ages 9 -12 years) using school health teams.

show abstract

Section: Discussionmentioning

confidence: 99%

High uptake of Gardasil vaccine among 9 - 12-year-old schoolgirls participating in an HPV vaccination demonstration project in KwaZulu-Natal Province

Moodley

Tathiah²,

Mubaiwa³

et al. 2013

S Afr Med J

View full text Add to dashboard Cite

show abstract

“…Various catch-up vaccinations are considered in few nations with financial means including Saudi Arabia. In terms of HPV vaccination program, available data from numerous developed nations indicate that school-based vaccination result in higher coverage of vaccines in comparison to provider-based vaccination (Brabin et al, 2008;LaMontagne et al, 2011). PATH or (Program for Appropriate Technology in Health) conducted demonstration projects in low income countries that also indicated that vaccination programs conducted at school attains high vaccine coverage (80-95%) (Luciani et al, 2009).…”

Section: Discussionmentioning

confidence: 99%

Perception of the Saudi Community towards Human Papilloma Virus Vaccination in Jeddah, Saudi Arabia

Al-Zahrani¹,

Alghanaim²,

Abdulmageed³

2017

GJHS

View full text Add to dashboard Cite

To examine the awareness and perception of Saudi community towards Human Papillomavirus Vaccination. A cross-sectional study has examined the perception and awareness of Saudi individuals towards Human Papillomavirus HPV vaccination. A sample of 278 Saudi individuals were included. A close-ended survey questionnaire was employed to collect the data of Papillomavirus HPV vaccination. Around, 78.30% female and male participants were unaware of the availability of HPV vaccination against cervical cancer. 90.06% of females supported cervical cancer screening Pap smear by gynecologist after enduring vaccination. Only, 40.66% visited the gynecologist for screening. Results demonstrated 85.77% female agreed on receiving expensive vaccination. Conversely, 97.48% supported on HPV vaccination free of charge. A lack of knowledge about HPV, Pap smear, and cervical cancer. The data obtained can be used as a standard to devise effective awareness programs. Data was collected particularly from Saudi Arabia for evaluating Saudi community perception. Both males and females were observed to be interested in taking vaccination and prevention initiatives against the cervical cancer, whereas, there is a lack of awareness observed among the males and females included in the study.

show abstract

“…[5] The high vaccine uptake observed in this HPV demonstration project is comparable to findings from other studies. [6][7][8] A schoolbased HPV vaccination programme in Brazil also found high rates of vaccine uptake -87.5%, 86.3% and 85.0% for the three doses, respectively. [6] A multicountry study of vaccination programmes in Peru, Uganda, Vietnam and India showed a high coverage in schoolbased programmes in the first 3 countries (>80%).…”

mentioning

confidence: 99%

“…[6] A multicountry study of vaccination programmes in Peru, Uganda, Vietnam and India showed a high coverage in schoolbased programmes in the first 3 countries (>80%). [7] In India, where a set of mixed strategies were used (school-based healthcare centres and community campaigns), coverage varied between 68.4% and 87.8%, depending on the populations targeted. [7] A study of the vaccination of 87 000 girls (9 -18 years) in 7 lowincome countries (Bhutan, Bolivia, Cambodia, Cameroon, Haiti, Lesotho and Nepal) using school-based strategies, health facility approaches, and combination school and facility models found a range of coverage rates depending on the delivery model.…”

mentioning

confidence: 99%

“…[7] In India, where a set of mixed strategies were used (school-based healthcare centres and community campaigns), coverage varied between 68.4% and 87.8%, depending on the populations targeted. [7] A study of the vaccination of 87 000 girls (9 -18 years) in 7 lowincome countries (Bhutan, Bolivia, Cambodia, Cameroon, Haiti, Lesotho and Nepal) using school-based strategies, health facility approaches, and combination school and facility models found a range of coverage rates depending on the delivery model. [8] Overall, for all the countries, the model using the health facility alone had a coverage of 77%, while the school-based and combination strategies had a coverage >90%.…”

mentioning

confidence: 99%

See 1 more Smart Citation

Human papillomavirus (HPV) vaccination of adolescents in the South African private health sector: Lessons from the HPV demonstration project in KwaZulu-Natal

2015

View full text Add to dashboard Cite

Human papillomavirus vaccine delivery strategies that achieved high coverage in low- and middle-income countries

Cited by 89 publications

References 19 publications

High uptake of Gardasil vaccine among 9 - 12-year-old schoolgirls participating in an HPV vaccination demonstration project in KwaZulu-Natal Province

High uptake of Gardasil vaccine among 9 - 12-year-old schoolgirls participating in an HPV vaccination demonstration project in KwaZulu-Natal Province

Perception of the Saudi Community towards Human Papilloma Virus Vaccination in Jeddah, Saudi Arabia

Human papillomavirus (HPV) vaccination of adolescents in the South African private health sector: Lessons from the HPV demonstration project in KwaZulu-Natal

Contact Info

Product

Resources

About